Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.43 USD | -1.07% | -0.08% | +18.66% |
Apr. 17 | Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing | MT |
Apr. 09 | ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension | CI |
Financials (USD)
Sales 2024 * | 535M | Sales 2025 * | 576M | Capitalization | 1.39B |
---|---|---|---|---|---|
Net income 2024 * | 22M | Net income 2025 * | 34M | EV / Sales 2024 * | 2.45 x |
Net cash position 2024 * | 80.28M | Net cash position 2025 * | 188M | EV / Sales 2025 * | 2.08 x |
P/E ratio 2024 * |
51.4
x | P/E ratio 2025 * |
32.2
x | Employees | 642 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.64% |
Latest transcript on ANI Pharmaceuticals, Inc.
1 day | -1.34% | ||
1 week | +0.09% | ||
Current month | -5.19% | ||
1 month | -5.83% | ||
3 months | +18.73% | ||
6 months | +12.84% | ||
Current year | +18.86% |
Managers | Title | Age | Since |
---|---|---|---|
Nikhil Lalwani
CEO | Chief Executive Officer | 46 | 20-09-07 |
Stephen Carey
DFI | Director of Finance/CFO | 53 | 16-05-05 |
Patrick Walsh
CHM | Chairman | 63 | 18-05-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Haughey
BRD | Director/Board Member | 60 | 18-04-30 |
Antonio Pera
BRD | Director/Board Member | 66 | 20-08-05 |
David Nash
BRD | Director/Board Member | 68 | 18-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.95% | 11 M€ | -6.03% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 65.43 | -1.07% | 83 439 |
24-04-23 | 66.14 | +0.79% | 85,940 |
24-04-22 | 65.62 | +0.21% | 95,322 |
24-04-19 | 65.48 | +1.39% | 207,268 |
24-04-18 | 64.58 | -1.37% | 184,179 |
Delayed Quote Nasdaq, April 24, 2024 at 02:50 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.86% | 1.39B | |
+25.68% | 672B | |
+25.87% | 570B | |
-5.26% | 360B | |
+16.75% | 321B | |
+8.44% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.70% | 149B |
- Stock Market
- Equities
- ANIP Stock